Dergiler / Experimental Biomedical Research / 2021 / Cilt: 4 - Sayı: 2

Investigation of the effect of quercetin in an experimental oxygen-induced retinopathy model

Sayfa
131–140
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Quercetin's anti-inflammatory and anti-angiogenesis effect was found to be similar to bevacizumab.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: To investigate of the effect of intraperitoneal (IP) quercetin and bevacizumab on oxygen-induced retinopathy (OIR) model in rats.
📊
Temel Bulgular & Veri:Methods: In the study, 28 newborn rats were used.
💡
Sonuç & Katkı:Quercetin's anti-inflammatory and anti-angiogenesis effect was found to be similar to bevacizumab.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Aim: To investigate of the effect of intraperitoneal (IP) quercetin and bevacizumab on oxygen-induced retinopathy (OIR) model in rats. Methods: In the study, 28 newborn rats were used. The OIR model was performed with the 50/10% oxygen technique. The study consisted of four groups as a control group (Group I) and OIR groups (Group II, III, and IV). IP injection applied to all groups on the postnatal day (PND) 14. Groups I and II were performed 0.9% NaCl, Group III was performed IP bevacizumab, and Group IV was performed IP quercetin. All animals were sacrificed on PND 18. Results: Based on the data obtained from immunohistochemical and histopathological examinations, the number of vascular endothelial cell (VEC), vascular endothelial growth factor (VEGF), and tumor necrosis factor-α (TNF-α) levels were significantly reduced in Group III and IV compared to Group II. VECs levels were 0±0, 32.69±5.77, 2.92±0.63, and 3.64±0.36 in Group I, Group II, Group III, and Group IV, respectively (p<0.001). Likewise, VEGF values were 0.15±0.01, 7.57±1.80, 2.45±0.45, and 2.46±0.49, respectively (p<0.001). As well as TNF-α values were 0.06±0.01, 8.22±2.24, 2.32±0.32, and 2.29±0.26 in Group I, Group II, Group III, and Group IV, respectively (p<0.001). There was no significant difference between Group III and Group IV in terms of VEC, VEGF and TNF-α values (range of p values was 0.96-1.00). Conclusion: The results of the present study showed that quercetin administration significantly reduced the VEC number and suppressed VEGF and TNF-α. Quercetin's anti-inflammatory and anti-angiogenesis effect was found to be similar to bevacizumab.

🔖

Bu Makaleye Atıf Yap

KAYMAZ, A., ULAŞ, F., ERİMŞAH, S., ÖZTABAG, C. K. (2021). Investigation of the effect of quercetin in an experimental oxygen-induced retinopathy model. Experimental Biomedical Research, Cilt: 4 - Sayı: 2, 131–140. https://ajindex.com/articles/210827

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Park SW, Kim JH, Kim KE, et al. Betalapachone inhibits pathological retinal neovascularization in oxygen-induced retinopathy via regulation of HIF-1alpha. J Cell Mol Med. 2014
  2. 18(5):875-84. [2]Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984
  3. 102(11):1640-42. [3]Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes. 1989
  4. 38(10):1203- 1206. [4]Sato T, Kusaka S, Shimojo H, et al. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Ophthalmology. 2009
  5. 116(9):1599-1603. [5]Seo S, Suh W. Antiangiogenic effect of dasatinib in murine models of oxygeninduced retinopathy and laser-induced choroidal neovascularization. Mol Vis. 2017
  6. Grilli M, Chiu JJ, Lenardo MJ. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol. 1993
  7. Moja L, Lucenteforte E, Kwag KH, et al. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2014(9):CD011230. [8]Arevalo JF, Sanchez JG, Fromow-Guerra J, et al. Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2009
  8. 247(6):735-43. [9]Mitchell P, Smith W, Wang JJ, et al. Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology. 1998
  9. 105(3):406- 11. [10]Lamson DW, Brignall MS. Antioxidants and cancer, part 3: quercetin. Altern Med Rev. 2000
  10. 5(3):196-208. [11]Chen B, He T, Xing Y, et al. Effects of quercetin on the expression of MCP-1, MMP-9 and VEGF in rats with diabetic retinopathy. Exp Ther Med. 2017
  11. 14(6):6022-26. [12]Ola MS, Ahmed MM, Shams S, et al. Neuroprotective effects of quercetin in diabetic rat retina. Saudi J Biol Sci. 2017
  12. 24(6):1186-94. [13]Li F, Bai Y, Zhao M, et al. Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro. Ophthalmic Res. 2015
  13. 53(3):109-16. [14]Kumar B, Gupta SK, Nag TC, et al. Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats. Exp Eye Res. 2014
  14. Penn JS, Henry MM, Tolman BL. Exposure to alternati